In a recent interview, Marie Josee van Rijn from Rotterdam, the Netherlands and Emma Wilton from Oxford, UK, provided insight into the transformative power of interventional approaches in the treatment of DVT. They also set the stage for the upcoming INARI Symposium at CX 2024, where they will focus on the critical importance of clot removal and its profound impact on the lives of patients with iliofemoral DVT.
Both van Rijn and Wilton agree that mechanical thrombectomy has enabled their centers to achieve an optimal patient pathway by providing interventionalists with a wider treatment window. ” It doesn’t really matter if the clot is two, six or eight weeks old, you can still intervene with ClotTriever. If you only had thrombolysis as a treatment option, that would matter and your therapy would fail”.
To learn more about INARI’s Symposium at CX 2024 click here.
This video was filmed by Inari Medical and is being sponsored for distribution in association with Vascular News, Interventional News and Venous News. Biba Medical bears no responsibility for the assets used in the production of this video.
